AMG510 (sotorasib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AMG510 (sotorasib), covering 2024-11-20 to 2024-11-20. Get the full timeline:
Most recent: Clinical Trial Update: AMG510 (sotorasib) Plus Lenvatinib As Second-line Treatment in Patients with KRASG12C Mutant, Metastatic NSCLC [Phase 2]